Bills · HR 5435
IN COMMITTEE· 119TH CONGRESS
House BillHR 5435Health
Stop CMV Act of 2025
INTRO SEP 17· LAST ACTION SEP 17
READING
4MIN
COSPONSORS
11
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenCongenital Cytomegalovirus (CMV) is a common viral infection, often silent at birth, but it's a leading cause of birth defects and developmental disabilities, including hearing loss and intellectual disabilities. Currently, newborn CMV screening is not universal, meaning many infants with the virus are not identified early enough to benefit from potential treatments.
This bill matters because it would create a framework and provide federal funding to encourage widespread CMV screening for newborns across the country. Early detection of CMV can allow for timely medical interventions that may prevent or lessen severe long-term health problems for affected children. If this bill becomes law, more families could learn about their child's CMV status sooner, leading to better health outcomes. If it doesn't pass, CMV screening would likely remain inconsistent, and public awareness and dedicated research funding might continue to lag, leaving more children vulnerable to preventable complications.
KEY PROVISIONS
5AI-extractedPROVISION 01
Allows hospitals and healthcare entities to administer congenital Cytomegalovirus (CMV) screening tests to infants 21 days old or younger.
This provision introduces the ability for widespread early detection of CMV in newborns, which is crucial for timely intervention.
PROVISION 02
States may prescribe standards and procedures for CMV testing, tracking, follow-up, and parent education; if a state does not, a federal advisory committee will establish these standards.
This ensures that screening procedures and information dissemination are in place across states, promoting consistency and accountability.
PROVISION 03
Authorizes federal grants through the Health Resources and Services Administration (HRSA) to states for distribution to hospitals to perform CMV testing.
Provides crucial financial support for the implementation of newborn CMV screening programs, making it feasible for states and hospitals.
PROVISION 04
Authorizes federal grants through the Centers for Disease Control and Prevention (CDC) to states for developing data collection systems and educating healthcare providers and the public about CMV.
Supports essential infrastructure for tracking CMV cases and raising awareness, which is key for prevention and management.
PROVISION 05
Directs the National Institutes of Health (NIH) to establish or expand research programs on CMV screening techniques, diagnostics, prevention, treatments, and vaccine development.
Funds vital research to improve future methods for detecting, preventing, and treating CMV, potentially leading to better outcomes for children.
SPONSORSHIP
1 + 11
R· New York
YRS IN OFFICE
3
BILLS LED
125
COSPONSOR BREAKDOWNBIPARTISAN · 36%
DEM 9 REP 2 IND 0
ACTION TIMELINE
2 EVENTSSEP 17
Introduced in House
SEP 17
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 5435
Congress119th
StatusIn Committee
IntroducedSep 17, 2025
Last actionSep 17, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED SEP 17, 2025
House BillHR 5435Health
Stop CMV Act of 2025
INTRODUCED SEP 17, 2025· LAST ACTION SEP 17, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
11
COMPLEXITY
Moderate
